Zobrazeno 1 - 10
of 187
pro vyhledávání: '"Katrina J Ruedy"'
Autor:
Laurel H, Messer, Bruce A, Buckingham, Fran, Cogen, Mark, Daniels, Greg, Forlenza, Rabab Z, Jafri, Nelly, Mauras, Andrew, Muir, R Paul, Wadwa, Perrin C, White, Steven J, Russell, Edward R, Damiano, Firas H, El-Khatib, Katrina J, Ruedy, Courtney A, Balliro, Zoey, Li, Martin Chase, Marak, Peter, Calhoun, Roy W, Beck
Publikováno v:
Diabetes Technology & Therapeutics. 24:712-725
Autor:
Roy W, Beck, Steven J, Russell, Edward R, Damiano, Firas H, El-Khatib, Katrina J, Ruedy, Courtney, Balliro, Zoey, Li, Peter, Calhoun
Publikováno v:
Diabetes Technology & Therapeutics. 24:681-696
Autor:
Jane, Lynch, Lauren G, Kanapka, Steven J, Russell, Edward R, Damiano, Firas H, El-Khatib, Katrina J, Ruedy, Courtney, Balliro, Peter, Calhoun, Roy W, Beck
Publikováno v:
Diabetes Technology & Therapeutics. 24:726-736
Autor:
William Biggs, Ian Orozco, Georgia Davis, Katrina J. Ruedy, Roy W. Beck, Janet B. McGill, Anuj Bhargava, Davida F. Kruger, Grazia Aleppo, William H. Polonsky, Quang T Nguyen, Laura A. Young, David Price, John B. Buse, Shichun Bao, Ryan Bailey, Peter Calhoun, Guillermo E. Umpierrez, Rodica Pop-Busui, Athena Philis-Tsimikas, K. Jean Lucas, Thomas W. Martens, Richard M. Bergenstal, Anne L. Peters
Publikováno v:
Diabetes Care
OBJECTIVE To explore the effect of discontinuing continuous glucose monitoring (CGM) after 8 months of CGM use in adults with type 2 diabetes treated with basal without bolus insulin. RESEARCH DESIGN AND METHODS This multicenter trial had an initial
Autor:
Steven J, Russell, Roy W, Beck, Edward R, Damiano, Firas H, El-Khatib, Katrina J, Ruedy, Courtney A, Balliro, Zoey, Li, Peter, Calhoun, R Paul, Wadwa, Bruce, Buckingham, Keren, Zhou, Mark, Daniels, Philip, Raskin, Perrin C, White, Jane, Lynch, Jeremy, Pettus, Irl B, Hirsch, Robin, Goland, John B, Buse, Davida, Kruger, Nelly, Mauras, Andrew, Muir, Janet B, McGill, Fran, Cogen, Jill, Weissberg-Benchell, Jordan S, Sherwood, Luz E, Castellanos, Mallory A, Hillard, Marwa, Tuffaha, Melissa S, Putman, Mollie Y, Sands, Gregory, Forlenza, Robert, Slover, Laurel H, Messer, Erin, Cobry, Viral N, Shah, Sarit, Polsky, Rayhan, Lal, Laya, Ekhlaspour, Michael S, Hughes, Marina, Basina, Betul, Hatipoglu, Leann, Olansky, Amrit, Bhangoo, Nikta, Forghani, Himala, Kashmiri, Francoise, Sutton, Abha, Choudhary, Jimmy, Penn, Rabab, Jafri, Maria, Rayas, Elia, Escaname, Catherine, Kerr, Ruby, Favela-Prezas, Schafer, Boeder, Subbulaxmi, Trikudanathan, Kristen M, Williams, Natasha, Leibel, M Sue, Kirkman, Kate, Bergamo, Klara R, Klein, Jean M, Dostou, Sriram, Machineni, Laura A, Young, Jamie C, Diner, Arti, Bhan, J Kimberly, Jones, Matthew, Benson, Keisha, Bird, Kimberly, Englert, Joe, Permuy, Kristina, Cossen, Eric, Felner, Maamoun, Salam, Julie M, Silverstein, Samantha, Adamson, Andrea, Cedeno, Seema, Meighan, Carol, Wysham
Publikováno v:
The New England journal of medicine. 387(13)
Currently available semiautomated insulin-delivery systems require individualized insulin regimens for the initialization of therapy and meal doses based on carbohydrate counting for routine operation. In contrast, the bionic pancreas is initialized
Autor:
Erin C, Cobry, Lauren G, Kanapka, Eda, Cengiz, Lori, Carria, Laya, Ekhlaspour, Bruce A, Buckingham, Korey K, Hood, Liana J, Hsu, Laurel H, Messer, Melissa J, Schoelwer, Emma, Emory, Katrina J, Ruedy, Roy W, Beck, Raj Paul, Wadwa, Linda, Gonder-Frederick, Deanna, Gabrielson
Publikováno v:
Diabetes Technol Ther
Introduction: Hybrid closed-loop systems increase time-in-range (TIR) and reduce glycemic variability. Person-reported outcomes (PROs) are essential to assess the utility of new devices and their impact on quality of life. This article focuses on the
Autor:
Laurel H Messer, Bruce A Buckingham, Fran Cogen, Mark Daniels, Gregory P. Forlenza, Rabab Jafri, Nelly Mauras, Andrew Muir, R. Paul Wadwa, Perrin White, Steven Russell, Edward R Damiano, Firas El-Khatib, Katrina J. Ruedy, Courtney Balliro, Zoey Li, Chase Marak, Peter Calhoun, Roy W. Beck
Publikováno v:
Diabetes Technology & Therapeutics.
The publisher of Diabetes TechnologiesTherapeutics officially withdraws the Just Accepted version of the article entitled, "Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomi
Autor:
Shichun Bao, Katrina J. Ruedy, Stayce E Beck, David Price, Nathan Cohen, Nelly Njeru, Thomas W. Martens, Peter Calhoun, Anne L. Peters, Roy W. Beck
Publikováno v:
Diabetes, Obesity & Metabolism
Basal insulin is often prescribed to patients with sub-optimally controlled type 2 diabetes (T2D); however, its therapeutic efficacy is inadequate in many. During the MOBILE study's baseline phase, we evaluated 173 participants' continuous glucose mo
Autor:
the MOBILE Study Group, Richard M. Bergenstal, David Price, John B. Buse, William H. Polonsky, K. Jean Lucas, William Biggs, Ian Orozco, Quang T. Nguyen, Thomas Martens, Janet B. McGill, Laura Young, Anuj Bhargava, Davida Kruger, Georgia Davis, Guillermo Umpierrez, Shichun Bao, Athena Philis-Tsimikas, Rodica Pop-Busui, Anne L. Peters, Peter Calhoun, Katrina J. Ruedy, Ryan Bailey, Roy W. Beck, Grazia Aleppo
Objective: To explore the effect of discontinuing continuous glucose monitoring (CGM) after 8 months of CGM use in adults with type 2 diabetes treated with basal without bolus insulin. Research Design and Methods: Multi-center trial with an initial r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68c97690fcfd2439ee569e171c77cde8
https://doi.org/10.2337/figshare.16607969
https://doi.org/10.2337/figshare.16607969
Autor:
Melissa J, Schoelwer, Lauren G, Kanapka, R Paul, Wadwa, Marc D, Breton, Katrina J, Ruedy, Laya, Ekhlaspour, Gregory P, Forlenza, Erin C, Cobry, Laurel H, Messer, Eda, Cengiz, Emily, Jost, Lori, Carria, Emma, Emory, Liana J, Hsu, Stuart A, Weinzimer, Bruce A, Buckingham, Rayhan A, Lal, Mary Clancy, Oliveri, Craig C, Kollman, Betsy B, Dokken, Daniel R, Cherñavvsky, Roy W, Beck, Mark D, DeBoer, Deanna, Gabrielson
Publikováno v:
Diabetes Technol Ther
Background: Studies of closed-loop control (CLC) in patients with type 1 diabetes (T1D) consistently demonstrate improvements in glycemic control as measured by increased time-in-range (TIR) 70–180 mg/dL. However, clinical predictors of TIR in user